Division of Molecular Cardiology, Research Institute of Angiocardiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Br J Pharmacol. 2010 Feb;159(4):919-27. doi: 10.1111/j.1476-5381.2009.00591.x. Epub 2010 Jan 28.
Thrombus formation is commonly associated with pulmonary arterial hypertension (PAH). Thrombin may thus play an important role in the pathogenesis and pathophysiology of PAH. Hence, we investigated the contractile effects of thrombin and its mechanism in pulmonary artery.
The cytosolic Ca(2+) concentrations (Ca(2+)), 20 kDa myosin light chain (MLC20) phosphorylation and tension development were evaluated using the isolated porcine pulmonary artery.
Thrombin induced a sustained contraction in endothelium-denuded strips obtained from different sites of a pulmonary artery, ranging from the main pulmonary artery to the intrapulmonary artery. In the presence of endothelium, thrombin induced a transient relaxation. The contractile effect of thrombin was abolished by either a protease inhibitor or a proteinase-activated receptor 1 (PAR(1)) antagonist, while it was mimicked by PAR(1)-activating peptide (PAR(1)AP), but not PAR(4)AP. The thrombin-induced contraction was associated with a small elevation of Ca(2+) and an increase in MLC20 phosphorylation. Thrombin and PAR(1)AP induced a greater increase in tension for a given Ca(2+) elevation than that obtained with high K(+)-depolarization. They also induced a contraction at a fixed Ca(2+) concentration in alpha-toxin-permeabilized preparations.
The present study revealed a unique property of the pulmonary artery. In contrast to normal arteries of the systemic circulation, thrombin induces a sustained contraction in the normal pulmonary artery, by activating PAR(1) and thereby increasing the sensitivity of the myofilament to Ca(2+). This responsiveness of the pulmonary artery to thrombin may therefore contribute to the pathogenesis and pathophysiology of PAH.
血栓形成通常与肺动脉高压(PAH)相关。因此,我们研究了凝血酶在肺动脉中的收缩作用及其机制。
使用分离的猪肺动脉评估细胞浆钙离子浓度(Ca(2+))、20 kDa 肌球蛋白轻链(MLC20)磷酸化和张力发展。
凝血酶在从肺动脉主干到肺内动脉的不同部位获得的去内皮化条带中引起持续收缩。在存在内皮的情况下,凝血酶诱导短暂松弛。蛋白酶抑制剂或蛋白酶激活受体 1(PAR(1))拮抗剂可消除凝血酶的收缩作用,而 PAR(1)激活肽(PAR(1)AP)模拟其作用,但 PAR(4)AP 则不模拟。凝血酶诱导的收缩与 Ca(2+)的轻微升高和 MLC20 磷酸化的增加有关。与高钾去极化相比,凝血酶和 PAR(1)AP 引起的张力增加对于给定的 Ca(2+)升高更大。它们还在α-毒素通透制剂中在固定的 Ca(2+)浓度下引起收缩。
本研究揭示了肺动脉的独特特性。与全身循环的正常动脉不同,凝血酶通过激活 PAR(1)在正常肺动脉中引起持续收缩,从而增加肌丝对 Ca(2+)的敏感性。因此,肺动脉对凝血酶的这种反应性可能有助于 PAH 的发病机制和病理生理学。